Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Pharmacogenet Genomics. 2009 Aug;19(8):567–576. doi: 10.1097/FPC.0b013e32832c14b8

Table 1.

Human NT5C3 polymorphisms. Locations in the gene, nucleotide sequence alterations, amino acid sequence alterations, and minor allele frequencies of polymorphisms in the four populations studied are listed. If a polymorphism had already been deposited in a public database (dbSNP or HapMap), an rs number is indicated. All other polymorphisms listed are unique to this study. Polymorphisms within exons have been boxed. IVS is intervening sequence. The numbering scheme for nucleotide positions is based on assignment of the (+1) position to the “A” in the translation initiation codon, with nucleotides 5’ to that position assigned negative, and those 3’ within the cDNA assigned positive numbers. Nucleotide positions in introns are numbered from the nearest splice site, with distances from 3’ splice junction assigned positive and distances from 5’ splice junctions assigned negative numbers. AA, African-American; CA, Caucasian-American; HCA, Han Chinese-American; MA, Mexican-American; FR, flanking region; UTR, untranslated region.

NT5C3 Polymorphism

Frequency of Variant Allele
Gene Location Nucleotide Nucleotide Change Amino Acid Change AA CA HCA MA HapMap and/or dbSNP
5’-FR -1273 A→C 0.100 0.000 0.000 0.008
5’-FR -1270 T→C 0.000 0.008 0.000 0.000
5’-FR -1145 T→G 0.200 0.358 0.258 0.442 rs34307182
5’-FR -1143 G→A 0.283 0.292 0.317 0.133 rs6976843
5’-FR -1018 T→C 0.008 0.000 0.000 0.000
5’-FR -944 T→C 0.008 0.000 0.000 0.000
5’-FR -884 G insertion 0.033 0.008 0.000 0.000
5’-FR -693 C→G 0.000 0.000 0.142 0.017
5’-FR -656 C→T 0.000 0.017 0.000 0.008
5’-FR -654 G→A 0.017 0.042 0.092 0.083
5’-FR -653 T→C 0.000 0.000 0.008 0.000
5’-FR -552 G→C 0.333 0.342 0.417 0.250 rs10262141
5’-FR -496 C→T 0.008 0.000 0.000 0.000
5’-FR -373 C→T 0.000 0.008 0.000 0.000
5’-FR -354 T→C 0.225 0.342 0.275 0.225 rs13228827
5’-FR -340 T→G 0.042 0.017 0.008 0.000
5’-FR -302 A→G 0.333 0.342 0.417 0.250 rs13228639
5’-FR -267 15 nucleotide tandem repeat 0.000 0.008 0.000 0.000
5’-FR -258 20 nucleotide tandem repeat 0.025 0.000 0.000 0.000

5’-UTR -194 T→C 0.000 0.000 0.000 0.008
5’-UTR -134 deletion of GGTGGG 0.008 0.000 0.000 0.000
5’-UTR -67 T→C 0.000 0.033 0.000 0.008

IVS 1 -5780 C→G 0.025 0.000 0.133 0.017
IVS 1 -5767 A→T 0.000 0.000 0.025 0.000
IVS 1 -5757 A→T 0.017 0.000 0.000 0.000
IVS 1 -5756 T→A 0.000 0.000 0.008 0.000
IVS 1 -5714 A→G 0.008 0.000 0.133 0.017
IVS 1 -5705 C→A 0.000 0.008 0.000 0.000
IVS 1 -5654 A→G 0.008 0.000 0.000 0.000
IVS 1 -5635 G→A 0.000 0.000 0.017 0.000
IVS 1 -5633 A→G 0.008 0.000 0.000 0.000
IVS 1 -5418 G→A 0.225 0.342 0.283 0.225 rs10230500
IVS 1 -5125 T→G 0.000 0.000 0.008 0.000
IVS 1 -5059 G→A 0.050 0.000 0.000 0.000
IVS 1 -4900 G→A 0.000 0.000 0.058 0.000
IVS 1 -4645 G→T 0.008 0.000 0.000 0.000
IVS 1 -19 A→C 0.000 0.009 0.000 0.000

Exon 2 9 T→C 0.033 0.017 0.008 0.000 rs17170223

IVS 2 139 A→G 0.008 0.000 0.000 0.000
IVS 2 -307 T→A 0.000 0.000 0.008 0.000
IVS 2 -237 G→A 0.017 0.000 0.000 0.000
IVS 2 -4 T→G 0.033 0.008 0.000 0.000
IVS 3 103 C→T 0.008 0.000 0.000 0.000
IVS 4 35 C→T 0.050 0.000 0.000 0.000
IVS 4 -114 G→A 0.025 0.017 0.008 0.000 rs11974256
IVS 5 77 C→G 0.000 0.000 0.008 0.000
IVS 5 266 G→A 0.250 0.342 0.417 0.242 rs3750119
IVS 5 430 G→A 0.250 0.342 0.417 0.242 rs3750118
IVS 5 533 T→G 0.008 0.000 0.000 0.000
IVS 5 548 A→T 0.000 0.000 0.000 0.008
IVS 5 647 G→T 0.000 0.000 0.000 0.008

Exon 6 276 C→T 0.250 0.342 0.417 0.242 rs3750117
Exon 6 306 T→C 0.100 0.000 0.000 0.000

IVS 6 9 A→G 0.000 0.042 0.000 0.008
IVS 6 -71 C→T 0.117 0.325 0.275 0.225 rs2392209

Exon 9 759 G→A 0.000 0.008 0.000 0.000

IVS 9 52 T→A 0.000 0.000 0.000 0.008
IVS 9 61 A→G 0.025 0.017 0.008 0.000
IVS 9 -267 A→G 0.225 0.342 0.283 0.225 rs2893457
IVS 9 -38 C→T 0.000 0.000 0.008 0.000

Exon 10 847 G→C Asp (283) His 0.000 0.000 0.000 0.008